Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Learn which bonds reduce taxes in retirement and how to use them effectively. This concise intro highlights practical tax-saving bond options.
24,018 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
In a surprising policy shift, trump announces sanctions relief aimed at easing global oil prices. Traders are watchin...
Ferrari's latest results underscore its asset-like status, delivering strong cash flow while preparing for an electri...
Alphabet stands at a crossroads: Sundar Pichai could pull in up to $692 million over three years, but half of that de...
SDNY prosecutors seek a new trial for Tornado Cash co-founder Roman Storm in October 2026, even as U.S. agencies ackn...
The Agent Impact Network has reached 385,000 agents, adding about 2,000 new members each month and expanding its inve...
Ethereum rose above 2,000 while a scarcity signal on Binance turned positive, suggesting thinner sell-side liquidity....
MercadoLibre stock slid 17% in the past month as JPMorgan cut its target to $2,100, citing fierce competition and mar...
United Airlines faces near term pressure from higher fuel costs, yet the Street remains optimistic with a consensus t...
Oil shipments face new risk as Iran signals deployment of sea mines in key chokepoints. Here’s how that could affect ...
A rare moment of optimism surrounds Uber as Dara Khosrowshahi signals a sharper focus on execution and profitability....
Investors pulled back from spot XRP ETFs this week, registering zero net inflows across seven trading sessions. XRP p...